Apogee Therapeutics (APGE) Prepaid Assets (2022 - 2026)
Apogee Therapeutics (APGE) reported Prepaid Assets of $3.4 million for Q1 2026, up 474.57% year-over-year from $586000.0 in Q1 2025, and down 69.85% on a QoQ basis from $11.2 million in Q4 2025.
Apogee Therapeutics (APGE) has 5 years of Prepaid Assets data on file, last reported at $3.4 million in Q1 2026.
- Quarterly Prepaid Assets rose 474.57% year-over-year to $3.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.4 million (up 474.57% YoY) and the FY2025 annual result came in at $11.2 million, up 501.94% from the prior year.
- Prepaid Assets fell to $3.4 million in Q1 2026 per APGE's latest filing, from $11.2 million in the prior quarter.
- Across five years, Prepaid Assets topped out at $12.8 million in Q3 2025 and bottomed at $57000.0 in Q4 2022.
- The 5-year median for Prepaid Assets is $2.7 million (2024), against an average of $3.7 million.
- The widest annual swing landed in 2023, when Prepaid Assets soared 5075.44%; it then sank 82.88% in 2025.
- Tracing APGE's Prepaid Assets over 5 years: stood at $57000.0 in 2022, then soared by 5075.44% to $2.9 million in 2023, then plunged by 37.12% to $1.9 million in 2024, then surged by 501.94% to $11.2 million in 2025, then plunged by 69.85% to $3.4 million in 2026.
- Per Business Quant, the three latest APGE Prepaid Assets figures stand at $3.4 million (Q1 2026), $11.2 million (Q4 2025), and $12.8 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Apogee Therapeutics | 5.53 Bn | 4.47 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.37 Mn |
| Dec 31, 2025 | 11.17 Mn |
| Sep 30, 2025 | 12.81 Mn |
| Jun 30, 2025 | 963,000.00 |
| Mar 31, 2025 | 586,000.00 |
| Dec 31, 2024 | 1.86 Mn |
| Sep 30, 2024 | 3.27 Mn |
| Jun 30, 2024 | 5.63 Mn |
| Mar 31, 2024 | 2.72 Mn |
| Dec 31, 2023 | 2.95 Mn |
| Sep 30, 2023 | 1.41 Mn |
| Jun 30, 2023 | 887,000.00 |
| Dec 31, 2022 | 57,000.00 |